185 related articles for article (PubMed ID: 18602747)
1. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
6. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
7. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
8. [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
Wang XH; Li SS; Yan AH; Lu CX; Guo YP
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):441-4. PubMed ID: 16624747
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
12. Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma.
Hlubek F; Pfeiffer S; Budczies J; Spaderna S; Jung A; Kirchner T; Brabletz T
Br J Cancer; 2006 Jun; 94(11):1672-7. PubMed ID: 16705313
[TBL] [Abstract][Full Text] [Related]
13. Aberrant changes of Wnt2/beta-catenin signaling pathway induced by sodium nitroprusside in human esophageal squamous cell carcinoma cell lines.
Wang W; Xue L; Liu H; Wang P; Xu P; Cai Y
Cancer Invest; 2010 Mar; 28(3):230-41. PubMed ID: 19857041
[TBL] [Abstract][Full Text] [Related]
14. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells.
Zhang W; Yan S; Liu M; Zhang G; Yang S; He S; Bai J; Quan L; Zhu H; Dong Y; Xu N
Cancer Lett; 2010 Oct; 296(1):113-22. PubMed ID: 20457486
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
Park CH; Hahm ER; Park S; Kim HK; Yang CH
FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin control of T-cell transcription factor 4 (Tcf4) importation from the cytoplasm to the nucleus contributes to Tcf4-mediated transcription in 293 cells.
Hsu HT; Liu PC; Ku SY; Jung KC; Hong YR; Kao C; Wang C
Biochem Biophys Res Commun; 2006 May; 343(3):893-8. PubMed ID: 16564030
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
